We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTS:NYSEWatts Water Technologies, Inc. Analysis

Data as of 2026-09-13 - not real-time

$356.02

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Watts Water Technologies, Inc. is priced at $356.02 and its moving averages line up in bullish order, the shorter sitting above the longer. It has gained 3.5% over the past 30 days. RSI sits at 44.8, which reads as neutral, and MACD momentum is bearish. Watch $347.11 as support and $387.39 as the nearer resistance level.
Multiples put this in fair territory: 31.1 times earnings against the sector's 28.0. The average analyst target implies 13.5% above today's level. Revenue is growing at 18.6% on a 14.3% profit margin. The 0.65% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 27.0%, a beta of 0.92 and a maximum drawdown of 15.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Watts Water Technologies reported past second-quarter 2026 results with sales rising to US$763.Watts Water Technologies NYSE:WTS reported strong Q2 2026 results with revenue and profit significantly above...On August 5, Watts Water Technologies NYSE:WTS reported second quarter results showing net sales of $763 million, up...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 317.83
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 31.1 versus sector average of 28.0
  • Trading above the 200-day average of 317.83

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 31.1 versus sector average of 28.0
  • Analyst targets imply +13.5% versus the current price
  • Revenue growth of +18.6%

Key Metrics & Analysis

Financial Health

Revenue Growth18.60%
Profit Margin14.34%
P/E Ratio31.1
ROE18.80%
ROA11.63%
Debt/Equity9.67
P/B Ratio5.7
Op. Cash Flow$397.9M
Free Cash Flow$228.8M
Industry P/E28.0

Technical Analysis

TrendBullish
RSI44.8
Support$347.11
Resistance$387.39
MA 20$367.12
MA 50$360.84
MA 200$317.83
MACDBearish
VolumeIncreasing
Fear & Greed Index93.14

Valuation

Fair Value$185.03
Target Price$404.00
Upside/Downside13.48%
GradeFair
TypeGrowth
Dividend Yield0.65%

Risk Assessment

Beta0.92
Volatility26.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.